Articles
| Open Access |
DOI: Circulating Tumor Cells: Atomic Properties And Hostile To Malignant Growth Treatment Checking
Kakharman Nogaibayeva, Gulbarshin Sultanova , Department Of The Chemotherapy Unit, Kazakh-Russian Medical University, KazakhstanAbstract
Presence of Сirculating tumor cells (CTCs) in blood of disease patients, affirms about a
scattering of malignant growth cells to the fringe circulatory system, on the most punctual
phases of malignancy improvement and all the time vouches for an unfavorable clinical ebb
and flow, particularly it is associated with arrangement of metastases. Moreover, these
phones can speak to the base lingering infection and quantitative observing of CTCs level in
time of hostile to malignant growth treatment furnishes specialiCDC with important data. For
now the job of epithelial-to-mesenchymal travel (EMT) and mesenchymal-to-epithelial travel
(MET) in arrangement of different subpopulations CTCs, in development of malignancy
forceful properties. In this article we need to demonstrate the reason and issues of our
logical exploration - the cytological atomic investigation of flowing tumor cells have
separated by the size ward ISET innovation.
Keywords
cell, disease
References
Syozil D.,Current status in human bosom disease micrometastasis. /Curr. Opin. Oncol.
;191, 148–163.
Trigo R.M., Palutikof Jean /Flowing tumor cells and bone marrow micrometastasis.
/Clin. Disease Res. 2006;4, 413–421.
Steyl G., /Metastasis: late revelations and novel treatment techniques. /Lancet
;119, 2142–2157.
Rounds Stewart AInserra, S. Diederichs, A.J. Iafrate, D.W. Chime, et al . /Recognition
of changes in EGFR in flowing lung-disease cells. /N. Engl. J. Prescription. 2004.
:266–277.
Article Statistics
Copyright License
Copyright (c) 2020 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.